Shilpa has increasingly established itself as one of few companies with integrated development, manufacturing and commercial expertise in complex sector of generic pharmaceuticals. We have a formidable track record of development around challenging patent landscapes. We develop, produce and market a portfolio of approximately 50 + high-quality and cost-effective generic medicines. We are constantly working for the breakthroughs in value-added generics that can help in furthering the patient’s access to affordable, high-quality healthcare.
Currently we are handling about ~ 50 niche products in our 8 manufacturing sites and 2 R&D centers. All the APIs and formulations are manufactured according to established international norms and rules. Vertical integration with our own APIs creates a synergistic effect in our business dealings and the end products on offer- which includes a complete range of products spanning across injectable, oral drugs as well as new drug delivery solutions.
To the best of our abilities, we shall strive to deliver the highest quality of products, always keeping our customers well- communicated. Shilpa is proud to offer a wide range of healthcare solutions spread across different therapeutic areas, to treat both widespread and rare conditions, as per the needs of all the relevant stake holders in domain of healthcare.